An institutional strategy to increase minority recruitment to therapeutic trials

Cancer Causes and Control

Volumn 24, Issue 10, 2013, Pages 1797-1809

  Anwuri, Victoria V ^a,b   Hall, Lannis E ^a,b,c   Mathews, Katherine ^d   Springer, Brian C ^e   Tappenden, Jennifer R ^a   Farria, Dione M ^a   Jackson, Sherrill ^f,g   Goodman, Melody S ^a   Eberlein, Timothy J ^a,b   Colditz, Graham A ^a,b,h  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

^c HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d Casa de Salud   (United States)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

^f The Breakfast Club Inc   (United States)

^g Betty Jean Kerr People's Health Centers   (United States)

^h BARNES JEWISH HOSPITAL   (United States)

Author keywords

Clinical trial; Disparities; Enrollment; Minority; Participation; Therapeutic trial

Indexed keywords

ARTICLE; CANCER CENTER; CANCER INCIDENCE; CANCER THERAPY; CAUCASIAN; CLINICAL PROTOCOL; CLINICAL TRIAL; CONCEPTUAL FRAMEWORK; DATA ANALYSIS; FOLLOW UP; HEALTH CARE DISPARITY; HEALTH PROGRAM; HUMAN; INTERNET; LEADERSHIP; MAJOR CLINICAL STUDY; MINORITY GROUP; NATIONAL HEALTH ORGANIZATION; POLICY; PRIORITY JOURNAL; RESEARCH SUBJECT;

CLINICAL TRIALS AS TOPIC; HEALTHCARE DISPARITIES; HUMANS; MINORITY GROUPS; NEOPLASMS; PATIENT PARTICIPATION; PATIENT SELECTION; UNITED STATES;

EID: 84884595526     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-013-0258-1     Document Type: Article

References (55)

1. Freedman LS, Simon R, Foulkes MA, et al (1995) Inclusion of women and minorities in clinical trials and the NIH revitalization act of 1993 - the perspective of NIH clinical trials. Control Clin Trials 16:277-285. Discussion 86-9, 93-309
2. Hohmann AA, Parron DL (1996) How the new NIH guidelines on inclusion of women and minorities apply: efficacy trials, effectiveness trials, and validity. J Consult Clin Psychol 64:851-855
3. (June 10, 1993) NIH Revitalization Act of 1993
4. (October 9, 2001) Amendment: NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research, October 2001
5. Christian MC, Trimble EL (2003) Increasing participation of physicians and patients from underrepresented racial and ethnic groups in National Cancer Institute-sponsored clinical trials. Cancer Epidemiol Biomarkers Prev 12:S277-S283
6. Murthy VH, Krumholz HM, Gross CP (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291:2720-2726
7. Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP (2007) Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol 14:3328-3334
8. Baquet CR, Ellison GL, Mishra SI (2008) Analysis of Maryland cancer patient participation in national cancer institute-supported cancer treatment clinical trials. J Clin Oncol 26:3380-3386
9. National Cancer Institute (2000) NCI-supported clinical trials: facts and figures. National Cancer Institute, Rockville
10. Movsas B, Moughan J, Owen J et al (2007) Who enrolls onto clinical oncology trials? A radiation patterns of care study analysis. Int J Radiat Oncol Biol Phys 68:1145-1150
11. Springfield S (2010) Racial and ethnic minorities accrual to NCI clinical trials. Center to Reduce Cancer Health Disparities, National Cancer Institute, NIH, Bethesdda, MD
12. US Bureau of the Census (2000) DP-1. Profile of general demographic characteristics: 2000. Census 2000 summary file 1 (SF 1) 100-percent data. US Census Bureau
13. Sateren WB, Trimble EL, Abrams J et al (2002) How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 20:2109-2117
14. Elliott TE, Elliott BA, Renier CM, Haller IV (2004) Rural-urban differences in cancer care: results from the lake superior rural cancer care project. Minn Med 87:44-50
15. Klabunde CN, Springer BC, Butler B, White MS, Atkins J (1999) Factors influencing enrollment in clinical trials for cancer treatment. South Med J 92:1189-1193
16. Ford JG, Howerton MW, Bolen S, et al (2005) Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Evidence report/technology assessment (Summ), pp 1-11
17. Tournoux C, Katsahian S, Chevret S, Levy V (2006) Factors influencing inclusion of patients with malignancies in clinical trials. Cancer 106:258-270
18. Ford JG, Howerton MW, Lai GY et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112:228-242
19. Adams-Campbell LL, Ahaghotu C, Gaskins M et al (2004) Enrollment of African Americans onto clinical treatment trials: study design barriers. J Clin Oncol 22:730-734
20. Holcombe RF, Jacobson J, Li A, Moinpour CM (1999) Inclusion of black Americans in oncology clinical trials: the Louisiana State University Medical Center experience. Am J Clin Oncol 22:18-21
21. Baquet CR, Commiskey P, Daniel Mullins C, Mishra SI (2006) Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictors. Cancer Detect Prev 30:24-33
22. Robinson SB, Ashley M, Haynes MA (1996) Attitude of African-Americans regarding prostate cancer clinical trials. J Community Health 21:77-87
23. Coyne CA, Demian-Popescu C, Brown P (2004) Rural cancer patients' perspectives on clinical trials: a qualitative study. J Cancer Educ 19:165-169
24. Brown DR, Fouad MN, Basen-Engquist K, Tortolero-Luna G (2000) Recruitment and retention of minority women in cancer screening, prevention, and treatment trials. Ann Epidemiol 10:S13-S21
25. Pinto HA, McCaskill-Stevens W, Wolfe P, Marcus AC (2000) Physician perspectives on increasing minorities in cancer clinical trials: an Eastern Cooperative Oncology Group (ECOG) Initiative. Ann Epidemiol 10:S78-S84
26. Advani AS, Atkeson B, Brown CL et al (2003) Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study. Cancer 97:1499-1506
27. Outlaw FH, Bourjolly JN, Barg FK (2000) A study on recruitment of black Americans into clinical trials through a cultural competence lens. Cancer Nurs 23:444-451. quiz 51-2
28. Hudson SV, Momperousse D, Leventhal H (2005) Physician perspectives on cancer clinical trials and barriers to minority recruitment. Cancer Control 12:S93-S96
29. Giuliano AR, Mokuau N, Hughes C et al (2000) Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors. Ann Epidemiol 10:S22-S34
30. Linden HM, Reisch LM, Hart A Jr et al (2007) Attitudes toward participation in breast cancer randomized clinical trials in the African American community: a focus group study. Cancer Nurs 30:261-269
31. Shavers VL, Lynch CF, Burmeister LF (2002) Racial differences in factors that influence the willingness to participate in medical research studies. Ann Epidemiol 12:248-256
32. George SL (1996) Reducing patient eligibility criteria in cancer clinical trials. J Clin Oncol 14:1364-1370
33. Fuks A, Weijer C, Freedman B, Shapiro S, Skrutkowska M, Riaz A (1998) A study in contrasts: eligibility criteria in a twenty-year sample of NSABP and POG clinical trials. J Clin Epidemiol 51:69-79
34. McCabe MS, Varricchio CG, Padberg RM (1994) Efforts to recruit the economically disadvantaged to national clinical trials. Semin Oncol Nurs 10:123-129
35. Elks ML (1993) The right to participate in research studies. J Lab Clin Med 122:130-136
36. Townsley CA, Selby R, Siu LL (2005) Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol 23:3112-3124
37. Swanson GM, Bailar JC 3rd (2002) Selection and description of cancer clinical trials participants-science or happenstance? Cancer 95:950-959
38. Wood CG, Wei SJ, Hampshire MK, Devine PA, Metz JM (2006) The influence of race on the attitudes of radiation oncology patients towards clinical trial enrollment. Am J Clin Oncol 29:593-599
39. Fracasso PM, Walker MS, Mathews KJ et al (2007) Coaching intervention as a strategy for enhancing accrual to phase I/II clinical trials. J Clin Oncol 2007 ASCO Annual Meeting Proceedings Part I 25:S6580
40. Fouad MN, Partridge E, Green BL et al (2000) Minority recruitment in clinical trials: a conference at Tuskegee, researchers and the community. Ann Epidemiol 10:S35-S40
41. Fouad MN, Partridge E, Wynn T, Green BL, Kohler C, Nagy S (2001) Statewide Tuskegee alliance for clinical trials. A community coalition to enhance minority participation in medical research. Cancer 91:237-241
42. Lai GY, Gary TL, Tilburt J et al (2006) Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials. Clin Trials 3:133-141
43. Sorensen G, Emmons K, Hunt MK et al (2003) Model for incorporating social context in health behavior interventions: applications for cancer prevention for working-class, multiethnic populations. Prev Med 37:188-197
44. Emmons K (2000) Behavioral and social science contributions to the health of adults in the United States. In: Smedley BD, Syme SL (eds) Promoting health: intervention strategies from social and behavioral research. The National Academies Press, Washington, DC, pp 254-321
45. Stetler CB, Mittman BS, Francis J (2008) Overview of the VA Quality Enhancement Research Initiative (QUERI) and QUERI theme articles: QUERI Series. Implement Sci 3:8
46. Stetler CB, McQueen L, Demakis J, Mittman BS (2008) An organizational framework and strategic implementation for system-level change to enhance research-based practice: QUERI Series. Implement Sci 3:30
47. Feussner JR, Kizer KW, Demakis JG (2000) The Quality Enhancement Research Initiative (QUERI): from evidence to action. Med Care 38:I1-I6
48. Siteman Cancer Center (2011) Institutional data safety and monitoring plan. Siteman Cancer Center, St. Louis
49. Percy C, Fritz A, Jack A et al (1976) International classification of diseases for oncology (ICD-O), 3rd (ICD-O-3) edn. World Health Organization, Geneva Switzerland
50. Morgenlander KH, Winters SB, Lin CJ, Robertson LB, Heron DE, Herberman RB (2008) Novel method for benchmarking recruitment of African American cancer patients to clinical therapeutic trials. J Clin Oncol 26:5074-5077
51. Siteman Cancer Center (2009) Monitoring accrual by gender: race and ethnicity. Siteman Cancer Center, St. Louis
52. Wright JR, Bouma S, Dayes I et al (2006) The importance of reporting patient recruitment details in phase III trials. J Clin Oncol 24:843-845
53. Corbie-Smith G, St George DM, Moody-Ayers S, Ransohoff DF (2003) Adequacy of reporting race/ethnicity in clinical trials in areas of health disparities. J Clin Epidemiol 56:416-420
54. Committee on Assuring the Health of the Public in the 21st Century, Board on Health Promotion and Disease Prevention, Institute of Medicine of the National Academies (2002) The Future of the Public's Health in the 21st Century. The National Academies Press, Washington, DC
55. Wagner EH (1998) Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract 1:2-4